OPK
OPKO Health, Inc. · Healthcare · Medical - Diagnostics & Research
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q2 2024
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 83 | -5 | 114.41M | $171.44M | +3 | −8 |
| Q1 2026 | 91 | +2 | 116.06M | $132.34M | +8 | −6 |
| Q4 2025 | 88 | 0 | 132.71M | $167.24M | +1 | −1 |
| Q3 2025 | 15 | -2 | 100.01M | $155.02M | — | −3 |
| Q2 2025 | 15 | 0 | 96.47M | $127.34M | +2 | −2 |
| Q1 2025 | 12 | +1 | 38.88M | $64.54M | +2 | −1 |
| Q4 2024 | 11 | -1 | 30.02M | $44.13M | — | −1 |
| Q3 2024 | 11 | +1 | 16.46M | $24.53M | +1 | — |
| Q2 2024 | 10 | — | 13.40M | $16.75M | — | — |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Geode Capital Management ✦ (passive) | 8.82M | — | $11.03M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | Geode Capital Management ✦ (passive) | 8.82M | — | $11.03M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | Norges Bank ✦ (passive) | 1.33M | — | $1.66M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | Millennium Management ✦ | 1.26M | — | $1.58M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | Two Sigma Investments ✦ | 606.49K | — | $758,110 | 0.0% | n/c | 1 | SEC ↗ |
| 6 | T. Rowe Price ✦ | 433.05K | — | $542,000 | 0.0% | n/c | 1 | SEC ↗ |
| 7 | Citadel Advisors ✦ | 344.33K | — | $430,417 | 0.0% | n/c | 1 | SEC ↗ |
| 8 | Citadel Advisors ✦ | 344.33K | — | $430,417 | 0.0% | n/c | 1 | SEC ↗ |
| 9 | Renaissance Technologies ✦ | 284.74K | — | $355,929 | 0.0% | n/c | 1 | SEC ↗ |
| 10 | GAMCO Investors ✦ | 175.00K | — | $218,750 | 0.0% | n/c | 1 | SEC ↗ |
| 11 | AQR Capital Management ✦ | 79.84K | — | $99,799 | 0.0% | n/c | 1 | SEC ↗ |
| 12 | AQR Capital Management ✦ | 79.84K | — | $99,799 | 0.0% | n/c | 1 | SEC ↗ |
| 13 | Gotham Asset Management ✦ | 59.10K | — | $73,870 | 0.0% | n/c | 1 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 231 holders, 200.30M shares, $226.79M reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.